Aggressive Surgical Management of Recurrent Lymph Node and Pancreatic Head Metastases of Resected Fibrolamellar Hepatocellular Carcinoma: A Case Report

  • Maciej Wojcicki Department of Hepatobiliary Surgery and Liver Transplantation, Marie Curie Hospital. Szczecin, Poland
  • Jerzy Lubikowski Department of Hepatobiliary Surgery and Liver Transplantation, Marie Curie Hospital. Szczecin, Poland
  • Mariola Post Department of Hepatobiliary Surgery and Liver Transplantation, Marie Curie Hospital. Szczecin, Poland
  • Tomasz Chmurowicz Department of Hepatobiliary Surgery and Liver Transplantation, Marie Curie Hospital. Szczecin, Poland
  • Anna Wiechowska-Kozlowska Department of Endoscopy, MSWiA Hospital. Szczecin, Poland
  • Marek Krawczyk Department of General, Transplant and Liver Surgery, Medical University of Warsaw. Warsaw, Poland
DOI: https://doi.org/10.6092/1590-8577/839
Keywords: Fibrolamellar hepatocellular carcinoma, Lymphatic Metastasis, Neoplasm Metastasis, Pancreas

Abstract

Context Fibrolamellar hepatocellular carcinoma is a rare liver tumor with the propensity to metastasize to the lymph nodes months or years after initial surgery. However, its metastatic spread to the pancreas was previously reported only in a child. Case report We present an unusual case of a young female patient who was repeatedly treated by surgical excision of abdominal and mediastinal lymph node recurrences between 2 and 6 years after left hepatic lobectomy for fibrolamellar hepatocellular carcinoma. At 8 years following her initial surgery, the patient was diagnosed with pancreatic head metastasis and a pancreaticoduodenectomy was performed. Postoperative course was uneventful and the patient did not experience recurrence within the last 18 months. Conclusion The metastasis of fibrolamellar hepatocellular carcinoma to the pancreas is highly exceptional but possible and its excision appears warranted as well.

Image: 11C-acetate PET/CT scan showing a decreased uptake of the tracer within the pancreatic head.

Downloads

Download data is not yet available.

References

Edmondson HA. Differential diagnosis of tumors and tumor-like lesions of liver in infancy and childhood. AMA J Dis Child. 1956;91:168-186.

Craig JR, Peters RL, Edmondson HA, Omata M. Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer. 1980;46:372-9.

McLarney JK, Rucker PT, Bender GN, Goodman ZD, Kahitani N, Ros PR. Fibrolamellar carcinoma of the liver: Radiologic-pathologic correlation. Radiographics. 1999;19:453-71.

El Serag HB, Davila JA. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology. 2004;39:798-803.

Tsilvidis B, Huet E, Lubrano J, Lacaze L, Lestrat JP, Francois A, et al. Late supradiaphragmatic lymph node recurrence following resection of fibrolamellar hepatocarcinoma: an unusual case. Surg Radiol Anat. 2010;32:123-127.

Stipa F, Yoon SS, Liau KH, Fong Y, Jarnagin WR, D’Angelica M, et al. Outcome of patients with fibrolamellar hepatocellular carcinoma. Cancer. 2006;106 (6):1331-8.

Ichikawa T, Federle MP, Grazioli L, Marsh W. Fibrolamellar hepatocellular carcinoma: pre- and posttherapy evaluation with CT and MR imaging. Radiology. 2000;217 (1):145-51.

Thirabanjasak D, Sosothikul D, Mahayosnond A, Thorner PS. Fibrolamellar carcinoma presenting as a pancreatic mass: case report and review of the literature. J Pediatr Hematol Oncol. 2009;31:370-2.

Ringe B, Wittekind C, Weimann A, Tusch G, Pilchmayr R. Results of hepatic resection and transplantation for fibrolamellar carcinoma. Surg Gynecol Obstet. 1992;175:299-305.

Pinna AD, Iwatsuki S, Lee RG, Todo S, Madariaga JR, Marsh JW, et al. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 1997; 26 (4), 877-883.

Kakar S, Burgart LJ, Batts KP, Garcia J, Jain D, Ferrell LD. Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis. Mod Pathol. 2005;18 (11):1417-23.

Sarode VR, Castellani R, Post A. Fine-needle aspiration cytology and differential diagnoses of fibrolamellar hepatocellular carcinoma metastatic to the mediastinum: case report. Diagn Cytopathol. 2002;26:95-8.

Ichiki Y, Sugio K, Baba T, Mizukami M, Oga T, Takenoyama M, et al. Mediastinal metastasis from a fibrolamellar hepatocellular carcinoma: report of a case. Surg Today. 2010;40:360-4.

Crowe A, Knight CS, Jhala D, Bynon SJ, Jhala NC. Diagnosis of metastatic fibrolamellar carcinoma by endoscopic ultrasound-guided fine needle aspiration. CytoJournal. 2011; doi: 10.4103/1742-6413.76495.

Epstein BE, Pajak TF, Haulk TL, Herpst JM, Order SE, Abrams RA. Metastatic nonresectable fibrolamellar hepatoma: prognostic features and natural history. Am J Clin Oncol. 1999;22:22-8.

11C-acetate PET/CT scan showing a decreased uptake of the tracer within the pancreatic head
Published
2012-09-10
How to Cite
WojcickiM., LubikowskiJ., PostM., ChmurowiczT., Wiechowska-KozlowskaA., & KrawczykM. (2012). Aggressive Surgical Management of Recurrent Lymph Node and Pancreatic Head Metastases of Resected Fibrolamellar Hepatocellular Carcinoma: A Case Report. JOP. Journal of the Pancreas, 13(5), 529-532. https://doi.org/10.6092/1590-8577/839
Issue
Vol 13 No 5 (2012): September - p. 470-547
Section
CASE REPORTS

Copyright (c) 2014 Maciej Wojcicki, Jerzy Lubikowski, Mariola Post, Tomasz Chmurowicz, Anna Wiechowska-Kozlowska, Marek Krawczyk

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

As a member of Publisher International Linking Association, PILA, iMedPub Group’s JOP follows the Creative Commons Attribution License and Scholars Open Access publishing policies. Journal of the Pancreas is the Council Contributor Member of Council of Science Editors (CSE) and following the CSE slogan Education, Ethics, and Evidence for Editors.